Jab1 Silencing Inhibits Proliferation and Sensitizes to Cisplatin in Biliary Tract Cancer
Cancer Research and Treatment. 2019;51(3):886-900 
Silencing of tripartite motif (TRIM) 29 inhibits proliferation and invasion and increases chemosensitivity to cisplatin in human lung squamous cancer NCI-H520 cells
Thoracic Cancer. 2015;6(1):31-37
Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis
Cancer Letters. 2010;296(1):27-34
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Yearbook of Surgery. 2011;2011:310-312
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Yearbook of Gastroenterology. 2010;2010:96-97
Depletion of Jab1 inhibits proliferation of pancreatic cancer cell lines
FEBS Letters. 2006;580(25):5836-5844
Targeting cyclin B1 inhibits proliferation and sensitizes breast cancer cells to taxol
BMC Cancer. 2008;8(1):
RNAi-mediated silencing of CD147 inhibits tumor cell proliferation, invasion and increases chemosensitivity to cisplatin in SGC7901 cells in vitro
Journal of Experimental & Clinical Cancer Research. 2010;29(1):
Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin
Bioscience Reports. 2017;37(2):BSR20160445
284 POSTER Silencing of LASP-1 influences zyxin localization, inhibits proliferation and reduces migration in breast cancer cells
European Journal of Cancer Supplements. 2005;3(2):80